drugset / Trial / NCT02101112

Bioavailability of Apixaban Crushed Tablet

NCT02101112 ↗

Phase 1 Completed 69 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to determine whether the bioavailability of apixaban crushed tablets suspended in water or mixed with applesauce is similar to the bioavailability of apixaban whole tablets administered orally.

Timeline

Start
2014-03
Primary completion
2014-05
Completion
2014-05

Outcome

Mixed primary results

paper Cmax and AUC met bioequivalence criteria for crushed tablets in water. PMID 27292282 ↗

paper Cmax and AUC decreased by 21.1% and 16.4%, respectively, with the lower bound of the CIs falling below the bioequivalence criteria for crushed tablets with applesauce. PMID 27292282 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Apixaban Small molecule 10 mg Oral

Indications